|
VPS72 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.297900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.883800E-02 |
| Normal-vs-Stage2 |
4.763600E-01 |
| Normal-vs-Stage3 |
3.460100E-02 |
| Normal-vs-Stage4 |
2.174300E-02 |
| Stage1-vs-Stage2 |
2.510100E-02 |
| Stage1-vs-Stage3 |
5.821400E-01 |
| Stage1-vs-Stage4 |
4.321800E-01 |
| Stage2-vs-Stage3 |
2.984000E-02 |
| Stage2-vs-Stage4 |
1.503670E-02 |
| Stage3-vs-Stage4 |
7.561800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.779810E-02 |
| Normal-vs-AfricanAmerican |
2.995600E-03 |
| Normal-vs-Asian |
8.013700E-04 |
| Caucasian-vs-AfricanAmerican |
7.616000E-02 |
| Caucasian-vs-Asian |
6.692100E-02 |
| AfricanAmerican-vs-Asian |
5.176400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.537600E-02 |
| Normal-vs-Female |
3.568200E-02 |
| Male-vs-Female |
7.684600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.157800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.166200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.125000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.287400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.355400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.721200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.555600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.572000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.773400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.927800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.581400E-01 |
| Classical-VS-Follicular |
3.92250000258443E-08 |
| Classical-VS-Other |
9.364000E-01 |
| Classical-VS-Normal |
8.14720000000824E-05 |
| Tall-VS-Follicular |
1.043510E-02 |
| Tall-VS-Other |
6.542000E-01 |
| Tall-VS-Normal |
1.820180E-01 |
| Follicular-VS-Other |
7.412400E-02 |
| Follicular-VS-Normal |
2.714100E-02 |
| Other-VS-Normal |
4.173800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.015000E-01 |
| Normal-vs-N1 |
6.834000E-02 |
| N0-vs-N1 |
2.397800E-01 |
|
|
